Get Started
This questionnaire will ask a series of questions about your asthma symptoms over the last 4 weeks.
The Nafsi Institute · Transform programPersistent weight gain is usually driven by insulin resistance, hormonal change and disrupted sleep, not just lack of discipline. This physician-led program combines prescription medication when appropriate, nutrition and strength guidance, Styku 3D body composition scans, and a full metabolic evaluation: fasting insulin, A1c, lipids, thyroid and ferritin.
A full year of support, because the first month is the easy part.
GLP-1 therapy when clinically appropriate: brand-name Zepbound, Wegovy, Ozempic or Mounjaro, or compounded semaglutide and tirzepatide from licensed 503A pharmacies. If insurance doesn't cover your medication, compounded options are included in your program.
Compounded medications are not FDA-approved and may differ from brand-name products. Questions about a compounded product's testing or licensing go to the dispensing pharmacy.
A 60-second, non-invasive infrared scan that measures body fat, lean mass, visceral fat, circumferences and posture, so you see real progress, not just a number on a scale.
Please answer the questions to the best of your ability. This will give us a score which is suggestive of excessive sleepiness.
If you answered yes to all three questions, you are at high risk for lung cancer. Please contact your doctor for lung cancer screening CT chest or call RPC to schedule one.